HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L A Parker Selected Research

Ondansetron (Zofran)

6/2013Effect of low doses of cannabidiolic acid and ondansetron on LiCl-induced conditioned gaping (a model of nausea-induced behaviour) in rats.
10/2000The antiemetic drug ondansetron interferes with lithium-induced conditioned rejection reactions, but not lithium-induced taste avoidance in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


L A Parker Research Topics

Disease

15Nausea
06/2015 - 10/2000
10Vomiting
06/2015 - 03/2001
1Hypothermia
10/2013
1Body Weight (Weight, Body)
10/2010
1Obesity
10/2010
1Ataxia (Dyssynergia)
07/2005
1Pleural Effusion (Pleural Effusions)
12/2004
1Wounds and Injuries (Trauma)
12/2004
1Hemothorax
12/2004
1Opioid-Related Disorders (Opiate Addiction)
10/2001

Drug/Important Bio-Agent (IBA)

7CannabinoidsIBA
06/2015 - 07/2005
6Lithium ChlorideIBA
10/2013 - 09/2010
5AntiemeticsIBA
06/2015 - 07/2005
3EndocannabinoidsIBA
02/2015 - 04/2009
3cannabidiolic acidIBA
10/2013 - 03/2013
3CannabidiolIBA
10/2013 - 04/2012
3muskIBA
08/2013 - 04/2009
3Cisplatin (Platino)FDA LinkGeneric
03/2013 - 04/2009
2glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA
02/2015 - 08/2013
2anandamide (arachidonylethanolamide)IBA
02/2015 - 11/2013
2SaccharinIBA
02/2015 - 03/2013
2RimonabantIBA
11/2013 - 04/2009
2Dronabinol (THC)FDA LinkGeneric
10/2013 - 03/2001
2Dopamine AntagonistsIBA
10/2013 - 10/2001
2Ondansetron (Zofran)FDA LinkGeneric
06/2013 - 10/2000
25-HT1A Serotonin ReceptorIBA
03/2013 - 04/2012
2NicotineFDA Link
04/2012 - 04/2009
2AM6545IBA
10/2010 - 09/2010
2AM 251 (AM251)IBA
09/2010 - 07/2005
1pentaethylenehexamineIBA
11/2013
1Metoclopramide (Reglan)FDA LinkGeneric
10/2013
1AcidsIBA
10/2013
1CB1 Cannabinoid Receptor (CB1 Receptor)IBA
10/2013
1LithiumIBA
08/2013
1Serotonin (5 Hydroxytryptamine)IBA
06/2013
18-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)IBA
03/2013
13- (2- hydroxy- 4- (1,1- dimethylheptyl)phenyl)- 4- (3- hydroxypropyl)cyclohexanolIBA
03/2013
1EmeticsIBA
03/2013
1HU 211 (HU 210)IBA
11/2012
1AutoreceptorsIBA
04/2012
1Amyloid (Amyloid Fibrils)IBA
12/2011
1GEBR-7bIBA
12/2011
1RolipramIBA
12/2011
1Cannabinoid Receptor AntagonistsIBA
10/2010
1SolutionsIBA
09/2010
1AM 6527IBA
09/2010
1cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA
04/2009
1Neurotransmitter Agents (Neurotransmitter)IBA
04/2009
1Tissue Plasminogen Activator (Alteplase)FDA Link
12/2004
1Naloxone (Narcan)FDA LinkGeneric
10/2001
1Antipsychotic Agents (Antipsychotics)IBA
10/2001
1Flupenthixol (Flupentixol)IBA
10/2001

Therapy/Procedure

3Therapeutics
06/2015 - 12/2004
3Drug Therapy (Chemotherapy)
10/2013 - 03/2001
1Blood Transfusion (Blood Transfusions)
12/2004